High-throughput molecular assays for inclusion in personalised oncology trials – State-of-the-art and beyond

Anders Edsjö^*, Hege G. Russnes, Janne Lehtiö, David Tamborero, Eivind Hovig, Albrecht Stenzinger, Richard Rosenquist, Agnieszka Janowska, Alba López Rioja, Albrecht Stenzinger, Ali Razzak, Anni Lepland, Antonio Marra, Anu Planken, Åslaug Helland, Attila Patocs, Beatrice Mainoli, Bettina Ryll, Birute Brasiuniene, Daniel KazdalDavid Tamborero, Dora Cerina, Ebba Hallersjö Hult, Edita Baltruškevičienė, Eduard Vrdoljak, Eivind Hovig, Elena Chavarria, Elena Garralda, Eline Aas, Elisa Bjørgo, Emile Voest, Giuseppe Curigliano, Gro Live Fagereng, Hans Gelderblom, Hege G. Russnes, Henk Verheul, Hans Timmer, Irene Brana, Iwona Lugowska, Janne Lehtiö, Jean Yves Blay, Julio Oliveira, Kadri Rekker, Kadri Toome, Katriina Jalkanen, Kjetil Taskén, Knut Smeland, Kristiina Ojamaa, Kristoffer Staal Rohrberg, Loic Verlingue, Manon Antouly, Mika Mustonen, Paola Zagami, Péter Nagy, Peter Nygren, Peter Asplund, Rasa Sabaliauskaite, Richard Rosenquist, Rui Henrique, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Sigmund Brabrand, Simon Ekman, Soemeya Haj Mohammad, Sonata Jarmalaite, Tanja Juslin, Tiina Kahre, Tina Kringelbach, Tormod Guren, Ulrik Lassen, Vince Kornél Grolmusz, Xenia Villabour AlberuShow 51 moreShow less